Maxwell Biosciences
PrivateLast Round
VC Round
Aug 5, 2025
Total Funding Raised
$12.65M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Maxwell Biosciences operates in Healthcare & Life Sciences and is based in Austin, Texas. Its latest recorded funding round was a VC Round in August 2025.
Maxwell Biosciences is a biotechnology company developing a drug platform for synthetic, immune-inspired small molecules to combat a broad spectrum of infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Maxwell Biosciences Comparables
Compare Maxwell Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Peptilogics | 77% | |
| Innovation Pharmaceuticals Inc. | 74% | |
| Oryn Therapeutics | 73% |
For institutional investors. Book with your work email.
Maxwell Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Aug 5, 2025 | ||||
| Grant | Oct 24, 2024 | ||||
| Seed | Mar 10, 2022 | ||||
| Angel | Apr 6, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Maxwell Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Keiretsu Forum | Seed |
| Das & Co. | Seed |
| DecentraNet | Seed |
| Longevitytech.fund | Seed |
| Harvard Business School Alumni Angels Association | Seed |
| Medical Technology Enterprise Consortium | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 74% MoM.
- May 13, 2026
Monthly visitors increased 31% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- recognized_asOct 25, 2026
In May '26, Maxwell Biosciences, Inc.'s experimental pneumonia drug receives FDA Qualified Infectious Disease Product status from the FDA; the preclinical candidate remains untested in people, with human trials planned for 2027.
- spins_off_companyAug 20, 2026
Maxwell Biosciences, Inc. spins off SHU as its first spinout, with SHU providing a private AI hosting platform.
For institutional investors. Book with your work email.
Maxwell Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Maxwell Biosciences's valuation, stock price, and market status.
Is Maxwell Biosciences a public or private company?
Maxwell Biosciences is a private company.
What is the current stock price of Maxwell Biosciences?
Maxwell Biosciences is a private company, so its shares have no public market price. Caplight tracks Maxwell Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Maxwell Biosciences worth (valuation)?
Valuation information for Maxwell Biosciences is not publicly available.
Can I buy Maxwell Biosciences stock?
Maxwell Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Maxwell Biosciences's last funding round?
Maxwell Biosciences's most recent funding round was VC Round on August 5, 2025.
Who are the main investors in Maxwell Biosciences?
Key investors in Maxwell Biosciences include DecentraNet.
Will Maxwell Biosciences IPO soon?
No public IPO plans have been announced for Maxwell Biosciences.
How can I track Maxwell Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Maxwell Biosciences's shares on secondary markets.